Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up / Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F; Brozzi, F; Ceccarelli, C; Viola, David; Piaggi, Paolo; Vitti, Paolo; Pacini, F; Elisei, Rossella. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 98(2013).
Autori interni: | |
Autori: | Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F; Brozzi, F; Ceccarelli, C; Viola, David; Piaggi, Paolo; Vitti, Paolo; Pacini, F; Elisei, Rossella |
Titolo: | Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. |
Anno del prodotto: | 2013 |
Digital Object Identifier (DOI): | 10.1210/jc.2012-4137 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.